A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
The bill’s titles are written by its sponsor.
Sep 9, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on September 9, 2015, in a previous session of Congress, but was not enacted.
Senior Senator from Minnesota
Read Text »
Last Updated: Sep 9, 2015
Length: 17 pages
Earlier Version — Introduced
This activity took place on a related bill, S. 214 (113th).
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 124.
S. 2019 (114th) was a bill in the United States Congress.
How to cite this information.
Civic Impulse. (2017). S. 2019 — 114th Congress: Preserve Access to Affordable Generics Act. Retrieved from https://www.govtrack.us/congress/bills/114/s2019
“S. 2019 — 114th Congress: Preserve Access to Affordable Generics Act.” www.GovTrack.us. 2015. July 23, 2017 <https://www.govtrack.us/congress/bills/114/s2019>
|title=S. 2019 (114th)
|accessdate=July 23, 2017
|author=114th Congress (2015)
|date=September 9, 2015
|quote=Preserve Access to Affordable Generics Act